NCT03714477

Brief Summary

Having the advantages of being minimally invasive and simple, extracorporeal shock wave lithotripsy (SWL) remains one of the treatment options for renal stones less than 2cm. Although SWL is the most minimally invasive surgical approach for stone, there are still some concern about its short and long term side effect. While, there are some evidences that SWL might lead to increase in new onset hypertension, investigator's recent study suggested it might also cause worsening of blood pressure control in patient with known hypertension. Therefore, further studies are needed to confirm the initial finding. This study recruits patients who have hypertension and are currently diagnosed to have renal stone and planned for SWL, in order to to investigate the effect of SWL on blood pressure control. After informed consent and background information have been obtained, patients will be randomized to either have routine SWL (treatment arm) or 6 months later (control arm). Group 1 patients will have blood pressure monitored for one day at home by an handy automated blood pressure measuring machine before SWL and 6 months after SWL. Group 2 patients will have blood pressure monitoring immediately and then 6 months later, just prior to the SWL.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 22, 2018

Completed
2.2 years until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

February 25, 2021

Status Verified

February 1, 2021

Enrollment Period

1.3 years

First QC Date

October 15, 2018

Last Update Submit

February 23, 2021

Conditions

Keywords

Worsening hypertensionRenal stone

Outcome Measures

Primary Outcomes (1)

  • The changes in mean 24hr systolic and diastolic blood pressure measurement

    For treatment arm, the changes in mean 24hr systolic and diastolic blood pressure measurement before SWL and 6 monthes after SWL For control arm, the changes in mean 24hr systolic and diastolic blood pressure measurement right after randomization and in 6 months.

    Baseline, 6 months

Secondary Outcomes (9)

  • Change in mean night time diastolic and systolic blood pressure

    Baseline, 6 months

  • Change in mean night time heart rate

    Baseline, 6 months

  • Change in mean morning-time diastolic and systolic blood pressure

    Baseline, 6 months

  • Change in mean morning-time heart rate

    Baseline, 6 months

  • Change in mean afternoon/evening diastolic and systolic blood pressure

    Baseline, 6 months

  • +4 more secondary outcomes

Study Arms (2)

Treatment Arm

ACTIVE COMPARATOR

immediate extracorporeal shock wave lithotripsy - subject will have SWL arranged in the next available list

Procedure: Extracorporeal shock wave lithotripsy

Control Arm

NO INTERVENTION

delayed extracorporeal shock wave lithotripsy - subject will have SWL done 6 months later

Interventions

A minimally invasive treatment for renal stone which was first introduced in early 1980's. It tries to fragment the renal stones by high-energy shockwave at the kidney from the outside.

Treatment Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Renal calculi of size 5-15 mm in maximal diameter and considered as suitable for SWL
  • Patient with known hypertension and on regular medical treatment with regular follow-up.
  • Patient with stable hypertension for at least 3 months

You may not qualify if:

  • Patients had previous SWL, kidney surgery, percutaneous nephrolithotomy, etc.
  • Patients with stones obviously required more than one section of SWL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Shatin, Hong Kong

Location

MeSH Terms

Conditions

HypertensionNephrolithiasis

Interventions

Lithotripsy

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsUltrasonic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Chi Fai NG, Md

    CUHK

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

October 15, 2018

First Posted

October 22, 2018

Study Start

January 1, 2021

Primary Completion

April 30, 2022

Study Completion

October 30, 2022

Last Updated

February 25, 2021

Record last verified: 2021-02

Locations